2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators

Details for Australian Patent Application No. 2007313295 (hide)

Owner Merck & Co., Inc.

Inventors Rossi, Michael A.; Mitchell, Helen J.; Kim, Yuntae; Meissner, Robert S.; Wang, Jiabing; Perkins, James J.

Agent Spruson & Ferguson

Pub. Number AU-A-2007313295

PCT Pub. Number WO2008/048540

Priority 60/852,594 18.10.06 US

Filing date 15 October 2007

Wipo publication date 24 April 2008

International Classifications

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/4436 (2006.01)

A61K 31/497 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/048540 Priority application(s): WO2008/048540

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313300-Molecules with reduced half-lives, compositions and uses thereof

2007313293-HIV integrase inhibitors